Global Placental Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Placental Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 87

Published Date: 10 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.

According to our (Global Info Research) latest study, the global Placental Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Placental Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Placental Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Placental Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Placental Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lifebank Stem Cell Banking, Cynata, Celularity, Athersys and Americord Registry, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Placental Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others

Market segment by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others

Market segment by players, this report covers
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Placental Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Placental Stem Cell Therapy, with revenue, gross margin and global market share of Placental Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Placental Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Placental Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Placental Stem Cell Therapy.
Chapter 13, to describe Placental Stem Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Placental Stem Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Placental Stem Cell Therapy by Type
1.3.1 Overview: Global Placental Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 Hematologic Malignancies and Disorders
1.3.4 Congenital Immunodeficiency Disorders
1.3.5 Metabolic Disorders
1.3.6 Neurological Disorders
1.3.7 Others
1.4 Global Placental Stem Cell Therapy Market by Application
1.4.1 Overview: Global Placental Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Specialty Clinics
1.4.3 Clinical Research Organizations
1.4.4 Research Institutes and Academies
1.4.5 Others
1.5 Global Placental Stem Cell Therapy Market Size & Forecast
1.6 Global Placental Stem Cell Therapy Market Size and Forecast by Region
1.6.1 Global Placental Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Placental Stem Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Placental Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Lifebank Stem Cell Banking
2.1.1 Lifebank Stem Cell Banking Details
2.1.2 Lifebank Stem Cell Banking Major Business
2.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
2.1.4 Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lifebank Stem Cell Banking Recent Developments and Future Plans
2.2 Cynata
2.2.1 Cynata Details
2.2.2 Cynata Major Business
2.2.3 Cynata Placental Stem Cell Therapy Product and Solutions
2.2.4 Cynata Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cynata Recent Developments and Future Plans
2.3 Celularity
2.3.1 Celularity Details
2.3.2 Celularity Major Business
2.3.3 Celularity Placental Stem Cell Therapy Product and Solutions
2.3.4 Celularity Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celularity Recent Developments and Future Plans
2.4 Athersys
2.4.1 Athersys Details
2.4.2 Athersys Major Business
2.4.3 Athersys Placental Stem Cell Therapy Product and Solutions
2.4.4 Athersys Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Athersys Recent Developments and Future Plans
2.5 Americord Registry
2.5.1 Americord Registry Details
2.5.2 Americord Registry Major Business
2.5.3 Americord Registry Placental Stem Cell Therapy Product and Solutions
2.5.4 Americord Registry Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Americord Registry Recent Developments and Future Plans
2.6 ReNeuron Group
2.6.1 ReNeuron Group Details
2.6.2 ReNeuron Group Major Business
2.6.3 ReNeuron Group Placental Stem Cell Therapy Product and Solutions
2.6.4 ReNeuron Group Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ReNeuron Group Recent Developments and Future Plans
2.7 ReeLabs
2.7.1 ReeLabs Details
2.7.2 ReeLabs Major Business
2.7.3 ReeLabs Placental Stem Cell Therapy Product and Solutions
2.7.4 ReeLabs Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ReeLabs Recent Developments and Future Plans
2.8 Mesoblast
2.8.1 Mesoblast Details
2.8.2 Mesoblast Major Business
2.8.3 Mesoblast Placental Stem Cell Therapy Product and Solutions
2.8.4 Mesoblast Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mesoblast Recent Developments and Future Plans
2.9 Pluristem Therapeutics
2.9.1 Pluristem Therapeutics Details
2.9.2 Pluristem Therapeutics Major Business
2.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
2.9.4 Pluristem Therapeutics Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pluristem Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Placental Stem Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Placental Stem Cell Therapy by Company Revenue
3.2.2 Top 3 Placental Stem Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Placental Stem Cell Therapy Players Market Share in 2022
3.3 Placental Stem Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Placental Stem Cell Therapy Market: Region Footprint
3.3.2 Placental Stem Cell Therapy Market: Company Product Type Footprint
3.3.3 Placental Stem Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Placental Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
6.1 North America Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Placental Stem Cell Therapy Market Size by Country
6.3.1 North America Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Placental Stem Cell Therapy Market Size by Country
7.3.1 Europe Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
9.1 South America Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Placental Stem Cell Therapy Market Size by Country
9.3.1 South America Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Placental Stem Cell Therapy Market Drivers
11.2 Placental Stem Cell Therapy Market Restraints
11.3 Placental Stem Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Placental Stem Cell Therapy Industry Chain
12.2 Placental Stem Cell Therapy Upstream Analysis
12.3 Placental Stem Cell Therapy Midstream Analysis
12.4 Placental Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Placental Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Placental Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Placental Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lifebank Stem Cell Banking Company Information, Head Office, and Major Competitors
Table 6. Lifebank Stem Cell Banking Major Business
Table 7. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
Table 8. Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lifebank Stem Cell Banking Recent Developments and Future Plans
Table 10. Cynata Company Information, Head Office, and Major Competitors
Table 11. Cynata Major Business
Table 12. Cynata Placental Stem Cell Therapy Product and Solutions
Table 13. Cynata Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cynata Recent Developments and Future Plans
Table 15. Celularity Company Information, Head Office, and Major Competitors
Table 16. Celularity Major Business
Table 17. Celularity Placental Stem Cell Therapy Product and Solutions
Table 18. Celularity Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Celularity Recent Developments and Future Plans
Table 20. Athersys Company Information, Head Office, and Major Competitors
Table 21. Athersys Major Business
Table 22. Athersys Placental Stem Cell Therapy Product and Solutions
Table 23. Athersys Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Athersys Recent Developments and Future Plans
Table 25. Americord Registry Company Information, Head Office, and Major Competitors
Table 26. Americord Registry Major Business
Table 27. Americord Registry Placental Stem Cell Therapy Product and Solutions
Table 28. Americord Registry Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Americord Registry Recent Developments and Future Plans
Table 30. ReNeuron Group Company Information, Head Office, and Major Competitors
Table 31. ReNeuron Group Major Business
Table 32. ReNeuron Group Placental Stem Cell Therapy Product and Solutions
Table 33. ReNeuron Group Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. ReNeuron Group Recent Developments and Future Plans
Table 35. ReeLabs Company Information, Head Office, and Major Competitors
Table 36. ReeLabs Major Business
Table 37. ReeLabs Placental Stem Cell Therapy Product and Solutions
Table 38. ReeLabs Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. ReeLabs Recent Developments and Future Plans
Table 40. Mesoblast Company Information, Head Office, and Major Competitors
Table 41. Mesoblast Major Business
Table 42. Mesoblast Placental Stem Cell Therapy Product and Solutions
Table 43. Mesoblast Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mesoblast Recent Developments and Future Plans
Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Pluristem Therapeutics Major Business
Table 47. Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
Table 48. Pluristem Therapeutics Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pluristem Therapeutics Recent Developments and Future Plans
Table 50. Global Placental Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 51. Global Placental Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 52. Breakdown of Placental Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Placental Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Placental Stem Cell Therapy Players
Table 55. Placental Stem Cell Therapy Market: Company Product Type Footprint
Table 56. Placental Stem Cell Therapy Market: Company Product Application Footprint
Table 57. Placental Stem Cell Therapy New Market Entrants and Barriers to Market Entry
Table 58. Placental Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Placental Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Placental Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Table 61. Global Placental Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 62. Global Placental Stem Cell Therapy Consumption Value by Application (2018-2023)
Table 63. Global Placental Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 64. North America Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Placental Stem Cell Therapy Raw Material
Table 95. Key Suppliers of Placental Stem Cell Therapy Raw Materials
List of Figures
Figure 1. Placental Stem Cell Therapy Picture
Figure 2. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. Hematologic Malignancies and Disorders
Figure 5. Congenital Immunodeficiency Disorders
Figure 6. Metabolic Disorders
Figure 7. Neurological Disorders
Figure 8. Others
Figure 9. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Placental Stem Cell Therapy Consumption Value Market Share by Application in 2022
Figure 11. Hospitals and Specialty Clinics Picture
Figure 12. Clinical Research Organizations Picture
Figure 13. Research Institutes and Academies Picture
Figure 14. Others Picture
Figure 15. Global Placental Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Placental Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Placental Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Placental Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Placental Stem Cell Therapy Consumption Value Market Share by Region in 2022
Figure 20. North America Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Placental Stem Cell Therapy Revenue Share by Players in 2022
Figure 26. Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Placental Stem Cell Therapy Market Share in 2022
Figure 28. Global Top 6 Players Placental Stem Cell Therapy Market Share in 2022
Figure 29. Global Placental Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 30. Global Placental Stem Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 31. Global Placental Stem Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 32. Global Placental Stem Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 33. North America Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. France Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 50. China Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. India Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 67. Placental Stem Cell Therapy Market Drivers
Figure 68. Placental Stem Cell Therapy Market Restraints
Figure 69. Placental Stem Cell Therapy Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Placental Stem Cell Therapy in 2022
Figure 72. Manufacturing Process Analysis of Placental Stem Cell Therapy
Figure 73. Placental Stem Cell Therapy Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Placental Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Placental Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 87

Published Date: 10 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.

According to our (Global Info Research) latest study, the global Placental Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Placental Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Placental Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Placental Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Placental Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Placental Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lifebank Stem Cell Banking, Cynata, Celularity, Athersys and Americord Registry, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Placental Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others

Market segment by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others

Market segment by players, this report covers
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Placental Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Placental Stem Cell Therapy, with revenue, gross margin and global market share of Placental Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Placental Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Placental Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Placental Stem Cell Therapy.
Chapter 13, to describe Placental Stem Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Placental Stem Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Placental Stem Cell Therapy by Type
1.3.1 Overview: Global Placental Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 Hematologic Malignancies and Disorders
1.3.4 Congenital Immunodeficiency Disorders
1.3.5 Metabolic Disorders
1.3.6 Neurological Disorders
1.3.7 Others
1.4 Global Placental Stem Cell Therapy Market by Application
1.4.1 Overview: Global Placental Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Specialty Clinics
1.4.3 Clinical Research Organizations
1.4.4 Research Institutes and Academies
1.4.5 Others
1.5 Global Placental Stem Cell Therapy Market Size & Forecast
1.6 Global Placental Stem Cell Therapy Market Size and Forecast by Region
1.6.1 Global Placental Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Placental Stem Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Placental Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Placental Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Lifebank Stem Cell Banking
2.1.1 Lifebank Stem Cell Banking Details
2.1.2 Lifebank Stem Cell Banking Major Business
2.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
2.1.4 Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lifebank Stem Cell Banking Recent Developments and Future Plans
2.2 Cynata
2.2.1 Cynata Details
2.2.2 Cynata Major Business
2.2.3 Cynata Placental Stem Cell Therapy Product and Solutions
2.2.4 Cynata Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cynata Recent Developments and Future Plans
2.3 Celularity
2.3.1 Celularity Details
2.3.2 Celularity Major Business
2.3.3 Celularity Placental Stem Cell Therapy Product and Solutions
2.3.4 Celularity Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celularity Recent Developments and Future Plans
2.4 Athersys
2.4.1 Athersys Details
2.4.2 Athersys Major Business
2.4.3 Athersys Placental Stem Cell Therapy Product and Solutions
2.4.4 Athersys Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Athersys Recent Developments and Future Plans
2.5 Americord Registry
2.5.1 Americord Registry Details
2.5.2 Americord Registry Major Business
2.5.3 Americord Registry Placental Stem Cell Therapy Product and Solutions
2.5.4 Americord Registry Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Americord Registry Recent Developments and Future Plans
2.6 ReNeuron Group
2.6.1 ReNeuron Group Details
2.6.2 ReNeuron Group Major Business
2.6.3 ReNeuron Group Placental Stem Cell Therapy Product and Solutions
2.6.4 ReNeuron Group Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ReNeuron Group Recent Developments and Future Plans
2.7 ReeLabs
2.7.1 ReeLabs Details
2.7.2 ReeLabs Major Business
2.7.3 ReeLabs Placental Stem Cell Therapy Product and Solutions
2.7.4 ReeLabs Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ReeLabs Recent Developments and Future Plans
2.8 Mesoblast
2.8.1 Mesoblast Details
2.8.2 Mesoblast Major Business
2.8.3 Mesoblast Placental Stem Cell Therapy Product and Solutions
2.8.4 Mesoblast Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mesoblast Recent Developments and Future Plans
2.9 Pluristem Therapeutics
2.9.1 Pluristem Therapeutics Details
2.9.2 Pluristem Therapeutics Major Business
2.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
2.9.4 Pluristem Therapeutics Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pluristem Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Placental Stem Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Placental Stem Cell Therapy by Company Revenue
3.2.2 Top 3 Placental Stem Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Placental Stem Cell Therapy Players Market Share in 2022
3.3 Placental Stem Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Placental Stem Cell Therapy Market: Region Footprint
3.3.2 Placental Stem Cell Therapy Market: Company Product Type Footprint
3.3.3 Placental Stem Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Placental Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
6.1 North America Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Placental Stem Cell Therapy Market Size by Country
6.3.1 North America Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Placental Stem Cell Therapy Market Size by Country
7.3.1 Europe Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
9.1 South America Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Placental Stem Cell Therapy Market Size by Country
9.3.1 South America Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Placental Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Placental Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Placental Stem Cell Therapy Market Drivers
11.2 Placental Stem Cell Therapy Market Restraints
11.3 Placental Stem Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Placental Stem Cell Therapy Industry Chain
12.2 Placental Stem Cell Therapy Upstream Analysis
12.3 Placental Stem Cell Therapy Midstream Analysis
12.4 Placental Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Placental Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Placental Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Placental Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lifebank Stem Cell Banking Company Information, Head Office, and Major Competitors
Table 6. Lifebank Stem Cell Banking Major Business
Table 7. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
Table 8. Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lifebank Stem Cell Banking Recent Developments and Future Plans
Table 10. Cynata Company Information, Head Office, and Major Competitors
Table 11. Cynata Major Business
Table 12. Cynata Placental Stem Cell Therapy Product and Solutions
Table 13. Cynata Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cynata Recent Developments and Future Plans
Table 15. Celularity Company Information, Head Office, and Major Competitors
Table 16. Celularity Major Business
Table 17. Celularity Placental Stem Cell Therapy Product and Solutions
Table 18. Celularity Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Celularity Recent Developments and Future Plans
Table 20. Athersys Company Information, Head Office, and Major Competitors
Table 21. Athersys Major Business
Table 22. Athersys Placental Stem Cell Therapy Product and Solutions
Table 23. Athersys Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Athersys Recent Developments and Future Plans
Table 25. Americord Registry Company Information, Head Office, and Major Competitors
Table 26. Americord Registry Major Business
Table 27. Americord Registry Placental Stem Cell Therapy Product and Solutions
Table 28. Americord Registry Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Americord Registry Recent Developments and Future Plans
Table 30. ReNeuron Group Company Information, Head Office, and Major Competitors
Table 31. ReNeuron Group Major Business
Table 32. ReNeuron Group Placental Stem Cell Therapy Product and Solutions
Table 33. ReNeuron Group Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. ReNeuron Group Recent Developments and Future Plans
Table 35. ReeLabs Company Information, Head Office, and Major Competitors
Table 36. ReeLabs Major Business
Table 37. ReeLabs Placental Stem Cell Therapy Product and Solutions
Table 38. ReeLabs Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. ReeLabs Recent Developments and Future Plans
Table 40. Mesoblast Company Information, Head Office, and Major Competitors
Table 41. Mesoblast Major Business
Table 42. Mesoblast Placental Stem Cell Therapy Product and Solutions
Table 43. Mesoblast Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mesoblast Recent Developments and Future Plans
Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Pluristem Therapeutics Major Business
Table 47. Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
Table 48. Pluristem Therapeutics Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pluristem Therapeutics Recent Developments and Future Plans
Table 50. Global Placental Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 51. Global Placental Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 52. Breakdown of Placental Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Placental Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Placental Stem Cell Therapy Players
Table 55. Placental Stem Cell Therapy Market: Company Product Type Footprint
Table 56. Placental Stem Cell Therapy Market: Company Product Application Footprint
Table 57. Placental Stem Cell Therapy New Market Entrants and Barriers to Market Entry
Table 58. Placental Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Placental Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Placental Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Table 61. Global Placental Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 62. Global Placental Stem Cell Therapy Consumption Value by Application (2018-2023)
Table 63. Global Placental Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 64. North America Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Placental Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Placental Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Placental Stem Cell Therapy Raw Material
Table 95. Key Suppliers of Placental Stem Cell Therapy Raw Materials
List of Figures
Figure 1. Placental Stem Cell Therapy Picture
Figure 2. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Placental Stem Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. Hematologic Malignancies and Disorders
Figure 5. Congenital Immunodeficiency Disorders
Figure 6. Metabolic Disorders
Figure 7. Neurological Disorders
Figure 8. Others
Figure 9. Global Placental Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Placental Stem Cell Therapy Consumption Value Market Share by Application in 2022
Figure 11. Hospitals and Specialty Clinics Picture
Figure 12. Clinical Research Organizations Picture
Figure 13. Research Institutes and Academies Picture
Figure 14. Others Picture
Figure 15. Global Placental Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Placental Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Placental Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Placental Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Placental Stem Cell Therapy Consumption Value Market Share by Region in 2022
Figure 20. North America Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Placental Stem Cell Therapy Revenue Share by Players in 2022
Figure 26. Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Placental Stem Cell Therapy Market Share in 2022
Figure 28. Global Top 6 Players Placental Stem Cell Therapy Market Share in 2022
Figure 29. Global Placental Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 30. Global Placental Stem Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 31. Global Placental Stem Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 32. Global Placental Stem Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 33. North America Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. France Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Placental Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 50. China Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. India Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Placental Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Placental Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 67. Placental Stem Cell Therapy Market Drivers
Figure 68. Placental Stem Cell Therapy Market Restraints
Figure 69. Placental Stem Cell Therapy Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Placental Stem Cell Therapy in 2022
Figure 72. Manufacturing Process Analysis of Placental Stem Cell Therapy
Figure 73. Placental Stem Cell Therapy Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now